President and Chief Executive Officer · HAEMONETICS CORP (HAE)

Christopher Simon

A named executive officer of HAEMONETICS in every fiscal year CompBrief holds from FY2017 to FY2026. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2026

$12,044,701

FY2025: $10,722,488

1st of 5 named executive officers at Haemonetics by FY2026 total.

5 named officers on file for HAEMONETICS, FY2026

See an example →

What this number hides

The filing gives the total. HAEMONETICS’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Compensation figures as of the proxy filed June 9, 2026 (DEF 14A).

Free

Get Christopher Simon’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Christopher Simon and every company like it: Velarion Intel, free for 3 days, no card →

Christopher Simon compensation by year

HAEMONETICS Summary Compensation Table · all 10 fiscal years held
In US dollars, as HAEMONETICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Salary$709,615$858,462$893,954$937,211$963,173$945,000$1,012,885$1,088,469$1,100,000$1,100,008
Bonus$0$0$0$0$0$0$0$0$0$0
Stock awards$6,205,816$4,396,692$4,586,629$5,493,885$5,096,181$5,319,246$5,924,933$6,320,923$7,026,668$7,561,987
Option awards$1,312,552$1,062,497$1,062,485$1,374,979$1,499,979$1,499,986$1,499,980$1,624,959$1,399,974$1,504,968
Non-equity incentive$698,708$1,399,830$1,980,000$1,563,408$1,038,461$908,523$2,200,000$2,447,500$1,131,625$1,834,250
Pension and deferred compensation$0$0$0$0$0$0$0$0$0$0
All other$100,307$128,315$27,742$28,721$27,600$29,465$48,597$63,262$64,221$43,488
Total$9,026,998$7,845,796$8,550,810$9,398,204$8,625,394$8,702,220$10,686,395$11,545,113$10,722,488$12,044,701

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: HAEMONETICS CORP DEF 14A filed June 9, 2026, accession 0000313143-26-000074, and prior-year filings. Open the filing on EDGAR.

How this page was built: the HAEMONETICS CORP filed document, accession 0000313143-26-000074. Every figure is read from that document and cited to the page and table it appears in. Filed June 9, 2026.

$9.0M
$7.8M
$8.6M
$9.4M
$8.6M
$8.7M
$10.7M
$11.5M
$10.7M
$12.0M
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
FY26
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2026 year-end
TypeUnvested unitsValue at year-endExercise price
PSU64,214$3,470,125—
PSU43,873$2,370,897—
PSU36,451$1,969,812—
RSU21,405$1,156,726—
RSU9,750$526,890—
RSU6,511$351,854—
RSU6,075$328,293—
Option20,589—$89.16
Option15,223—$57.60
Option46,342—$70.31
Option24,105—$95.73

Per the Outstanding Equity Awards at Fiscal Year-End table in HAEMONETICS CORP's FY2026 proxy; value at the fiscal year-end close, as the company printed it.

HAEMONETICS’s named executive officers, FY2026

as the company reported each
Named executive officerRoleFY2026 total
Christopher Simon · this pagePresident and Chief Executive Officer$12,044,701
James D'AreccaExecutive Vice President, Chief Financial Officer$3,623,016
Michelle BasilExecutive Vice President, General Counsel$3,409,543
Frank ChanExecutive Vice President, Chief Operating Officer$3,336,849
Roy GalvinExecutive Vice President, Chief Commercial Officer$3,039,118

Board service

HAEMONETICS board · FY2021–FY2026

How this board is paid

Company policy: HAEMONETICS pays directors a $65,000 cash retainer and $200,000 in RSUs. As stated in HAEMONETICS's FY2026 proxy.

The full HAEMONETICS compensation record

free company brief

This page is one person within HAEMONETICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the HAEMONETICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order HAEMONETICS's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are HAEMONETICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order HAE

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Christopher Simon's compensation dossier